Callos Andrew sold CYTK
March 31, 2026 · Form 4 insider transaction
Callos Andrew sold 3,639 shares of Cytokinetics, Incorporated at $65.00 per share, a transaction worth $236.5K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
3,639
Price
$65.00
Total value
$236.5K
InsiderCallos Andrew
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 31, 2026
Filing dateMarch 31, 2026
Shares owned after66,004
OwnershipDirect
10b5-1 planNo
AmendedNo